Search

Space-air-ground integrated networks (SAGINs) are attracting increasing attention for extending wireless communication coverage. Furthermore, high-altitude platform stations (HAPSs) can provide low-latency internet access to areas where terrestrial networks do not operate as unmanned flying base stations. However, as more frequency bands are used by wireless communication systems in terrestrial and non-terrestrial networks, it is necessary to make effective use of the finite frequency bands for multiple systems. Therefore, this study focuses on frequency sharing between the uplink from HAPS to satellite and the downlink from HAPS to ground users for efficient use of finite frequency bands in a SAGIN. In such frequency sharing, the back lobe toward the rear of the HAPS antenna for uplink communication causes interference when receiving the downlink signal from HAPS. Therefore, the zero-forcing (ZF) method is applied to the directivity control of the HAPS-mounted uplink antenna, which helps direct the nulls with significantly low antenna gain toward ground users. However, the coverage of the nulls due to the above control alone is extremely insignificant, which cannot sufficiently guarantee interference suppression for diverse user distributions. Therefore, this study proposes a HAPS-based null broadening approach with directivity control according to the user distribution for interference suppression in a SAGIN. The effectiveness of our proposal is evaluated by comparing it with the existing covariance matrix tapper(CMT)-based null broadening, ZF-based nulling, and no nulling for the HAPS-mounted uplink antenna using numerical analysis.

Cynomolgus and rhesus macaques are frequently used in preclinical trials due to their close evolutionary relationships to humans. We conducted an initial screening for genetic variants in cynomolgus and rhesus macaque genes orthologous to human CYP3A4 and CYP3A5. Genetic screening of 78 Indochinese and Indonesian cynomolgus macaques and 34 Chinese rhesus macaques revealed a combined total of 42 CYP3A4 genetic variants, including 12 nonsynonymous variants, and 34 CYP3A5 genetic variants, including nine nonsynonymous variants. Four of these nonsynonymous variants were located at substrate recognition sites or the heme-binding region, domains essential for protein function, including c.886G>A (V296M) and c.1310G>A (S437N) in CYP3A4 and c.1437C>G (N479K) and c.1310G>C (T437S) in CYP3A5. The mutant proteins of these genetic variants were expressed in Escherichia coli and purified. Metabolic activity of these proteins measured using midazolam and nifedipine as substrates showed that none of these protein variants substantially influences the drug-metabolizing capacity of CYP3A4 or CYP3A5 protein. In Indonesian cynomolgus macaques, we also found IVS3+1delG in CYP3A4 and c.625A>T in CYP3A5, with which an intact protein cannot be produced due to a frameshift generated. Screening additional genomes revealed that two of 239 animals and three of 258 animals were heterozygous for IVS3+1delG of CYP3A4 and c.625A>T of CYP3A5, respectively. Some genetic variants were unevenly distributed between Indochinese and Indonesian cynomolgus macaques and between cynomolgus and rhesus macaques. Information on genetic diversity of macaque CYP3A4 and CYP3A5 presented here could be useful for successful drug metabolism studies conducted in macaques.

In mammals, circadian genes, Clock, Arntl(also known as Bmal1), Cry1, Cry2, Per1, Per2, and Per3, are rhythmically transcribed every 24 h in almost all organs and tissues to tick the circadian clock. However, their expression and function in oocytes and preimplantation embryos have not been investigated. In this study we found that the circadian clock may stop in mouse oocytes and preimplantation embryos. Real-time PCR analysis revealed the presence of transcripts of these genes in both oocytes and preimplantation embryos; however, their amounts did not oscillate every 24 h in one- to four-cell and blastocyst-stage embryos. Moreover, immunofluorescence analyses revealed that CLOCK, ARNTL, and CRY1 were localized similarly in the nuclei of germinal vesicle (GV) oocytes and one-cell- to four-cell-stage embryos. Because CRY1 is known to interact with the CLOCK-ARNTL complex to suppress transcription-promoting activity of the complex for genes such as Wee1, Cry2, Per1, Per2, and Per3in cells having the ticking circadian clock, we hypothesized that if the circadian clock functions in GV oocytes and one-cell- to four-cell-stage embryos, CLOCK, ARNTL, and CRY1 might suppress the transcription of these genes in GV oocytes and one-cell- to 4-cell-stage embryos as well. As a result, knockdown of CRY1 in GV oocytes by RNA interference did not affect the transcription levels of Wee1, Cry2, Per1, Per2, and Per3, but it reduced maturation ability. Thus, it seems that circadian genes are not involved in circadian clock regulation in mouse oocytes and preimplantation embryos but are involved in physiologies, such as meiosis.